• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

VVUS:US

3.3500 USD 0.0300 0.90%

As of 20:10:00 ET on 11/26/2014.

Snapshot for VIVUS Inc (VVUS)

Open: 3.3600 Day's Range: 3.3300 - 3.4200 Volume: 1,252,342
Previous Close: 3.3200 52wk Range: 2.9699 - 10.2900 1-Yr Rtn: -66.57%

Stock Chart for VVUS

No chart data available.
  • VVUS:US 3.3500
  • 1D
  • 1M
  • 1Y
3.3200
Interactive VVUS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for VVUS

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.4399
Est. EPS (USD) (12/2014) -0.7970
Est. PEG Ratio -
Market Cap (M USD) 347.32
Shares Outstanding (M) 103.68
30 Day Average Volume 1,766,551
Price/Book (mrq) 3.2781
Price/Sale (ttm) 2.5289
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/24/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for VVUS

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for VVUS

VIVUS, Inc. is a biopharmaceutical company developing therapies for obesity, sleep apnea, diabetes and sexual health. The company markets a treatment for erectile dysfunction, and has drugs for obesity and erectile dysfunction in late-stage clinical trials.

Seth H Z FischerCEO/Chief Commercial OfficerGuy P MarshVP:US Ops/General Manager
Wesley W DayVP:Clinical Development
More Company Profile & Key Executives for VVUS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil